BHC:NYSE
Valeant Pharmaceuticals
8,35 USD
arrow_upward
+1,15%(+0,095) 1D
8,33 USD
arrow_downward
−0,24% (−0,020)bedtimeNakon radnog vremena
Zatvoreno: 13. stu, 16:00:03 GMT -5 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za BHC...
Otvori
8,25 USD
Najviša
8,40 USD
Najniža
8,18 USD
Trž. kap.
3,13 mlr.
Prosj. kol.
3,86 mil.
Količina
2,34 mil.
52-tjed. najviša
9,04 USD
52-tjed. najniža
4,33 USD
EPS
−2,29 USD
Beta
0,30
Dionice u optjecaju
374,27 mil.
Broj djelatnika
20 tis.
Otvori
8,25 USD
Najviša
8,40 USD
Najniža
8,18 USD
Trž. kap.
3,13 mlr.
Prosj. kol.
3,86 mil.
Količina
2,34 mil.
52-tjed. najviša
9,04 USD
52-tjed. najniža
4,33 USD
EPS
−2,29 USD
Beta
0,30
Dionice u optjecaju
374,27 mil.
Broj djelatnika
20 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Zacks
·
prije 2 dana
Here's Why Bausch Health (BHC) is a Strong Momentum Stock
Profil
Bausch Health Companies Inc. is a pharmaceutical company headquartered in Laval, Quebec, Canada, with office in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
Valeant Pharmaceuticals – informacije
Glavni izvršni direktorThomas J. Appio
Zaposlenici20,3 tis.
Osnovano1960
SjedišteLaval, Québec, Kanada
SektorHealth Care
Djelatnost-
Web-lokacijabauschhealth.com